An Open-Label, Non-Randomised Study of 20 mg GW406381 Single Dose Pharmacokinetics in Healthy Subjects and in Volunteers With Moderate Hepatic Impairment.
Phase of Trial: Phase I
Latest Information Update: 14 Sep 2017
At a glance
- Drugs GW 406381 (Primary)
- Indications Musculoskeletal pain; Osteoarthritis; Rheumatoid arthritis
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline
- 15 Oct 2008 Actual start date changed from Sep 2005 to Oct 2005 as reported by Clinicaltrials.gov.
- 17 Aug 2007 Status change from recruiting to completed.
- 21 Nov 2006 New trial record.